SCHEDULE 13G

Statement of Beneficial Ownership

X4 Pharmaceuticals, Inc Filed 2026-09-21 Acc 0001738048-26-000071

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-09-21 SCHEDULE 13G Statement of Beneficial Ownership
2026-07-30 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)